Weight Management

 
Weight Management Treatments Underused among Primary Care Patients with Obesity: Daily Dose
February 22, 2024

Your daily dose of the clinical news you may have missed.

Weight Management Treatments Underused among Primary Care Patients with Obesity Despite Their Effectiveness
February 16, 2024

In a new study of primary care patients with obesity, bariatric surgery offered the greatest probability of 1-year weight loss of ≥5%, at 93%.

Eating Disorder Hospitalizations Increasing among US Adolescents: Daily Dose
February 15, 2024

Your daily dose of the clinical news you may have missed.

T2D Remission After Gastric Bypass Persists, Despite Weight Regain
February 14, 2024

People with T2D and obesity who had gastric bypass surgery maintained significant levels of disease remission, despite up to 100% weight regain, study finds.

Tirzepatide Linked to “Impressive” BP Reduction in Adults with Obesity: Daily Dose
February 12, 2024

Your daily dose of the clinical news you may have missed.

Novel Weight Loss Entrant from Amgen Challenges Duration of Effect and Dosing with Wegovy, Zepbound
February 08, 2024

Amgen's investigational maridebart cafraglutide in a phase 1 trial led to durable weight reduction following less frequent and lower doses, the company said.

Tirzepatide Associated with "Impressive" BP Reduction in Individuals with Obesity
February 06, 2024

Mean placebo-adjusted SBP change from baseline at 36 weeks was 8.6 mm Hg in adults with obesity, according to authors of the SURMOUNT-1 ABPM substudy.

HbA1c Greater than 6.0% Raises T2D Risk in Children with Obesity: Daily Dose
February 02, 2024

Your daily dose of the clinical news you may have missed.

Eating Disorder Hospitalizations Rising among US Adolescents, New Study Warns
February 02, 2024

Eating disorders among US youth spiked during the COVID-19 pandemic, but a new study shows hospitalizations have been inching up for a decade or more.

Baseline HbA1c Greater than 6.0% Linked to "Exponential" Increase in T2D Risk for Adolescents with Obesity
January 24, 2024

Adolescents with overweight or obesity and baseline HbA1c 6.3%-6.4% were at 72-fold greater risk for T2D than those with HbA1c of 5.5%, a new cohort study finds.